Score Your Stock

US stock · figures in US dollars · scored on full-year results

Labcorp Labcorp Holdings Inc. Common Stock

LH · Healthcare · Diagnostics & Research
Top 21% of scored stocks
OkayTop 21% of scored stocks

Labcorp scores 65/100 on fundamentals: in the top 21% of 503 scored S&P 500 stocks. Its strongest area is Financial Safety (83/100); its weakest is Price Fairness (33/100).

Best
Financial 83
Weakest
Price 33

A financially strong, expensively priced stock, but price fairness needs attention.

What looks good
What to watch
Mkt capUS$ 29.4b#325 of 503 in the S&P 500EPSUS$ 12.20P/E29.1×✓ vs sector median 30.5×P/B3.4×✓ vs sector median 4×Div yield1%Bottom 35% in the S&P 50052w range · 93% of range244.52371.00
as of 31 Oct 2026

Nearby peers

Ranks #9 of 60 in Healthcare by score

#1Universal Health Services79#7Cooper Companies66#8Intuitive Surgical66
#9Labcorp65
#10Veeva Systems65#11GE HealthCare64

One-Minute Summary

Why Labcorp scores 65

A financially strong, expensively priced stock, but price fairness needs attention.

What looks good
What to watch

Business Strength

70
Why 70?
Pillar score: (1 + 1 + 2 + 1 + 2) = 7 of 10 points → 70
Return on Equity (ROE)12%Okay4-Year Revenue Growth+6%/yrOkay4-Year Profit Growth+34%/yrStrongNet Profit Margin7%OkayQuarterly Momentum+6%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +140.2%Equity ↑ +9.3%ROE % 11.7%
Net ProfitEquityROE %
418m746m877m1.0b7.9b8.1b8.6b8.6b202320242025TTM5.3%9.3%10.2%11.7%

Revenue & Net Profit, with Net Margin

Revenue ↑ +20%Net Profit ↑ +140.2%Net Margin % 6.9%
RevenueNet ProfitNet Margin %
12.2b13.0b14.0b14.6b418m746m877m1.0b202320242025TTM3.4%5.7%6.3%6.9%

Sales grew about 20% over 4 years: customers keep spending more with this company.

Profit climbed about 140.2% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +13.7%Net Profit ↑ +76.4%Net Margin % 8%
RevenueNet ProfitNet Margin %
3.3b3.3b3.3b3.5b3.6b3.5b3.5b3.7b169m143m213m238m261m165m278m299mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'265.2%4.3%6.4%6.7%7.3%4.7%7.9%8%
▼▲▼▲▲▲▲▲

Sales grew about 13.7% over the last 8 quarters: customers keep spending more with this company.

Profit grew about 76.4% over the last 8 quarters: the business is keeping more of what it earns.

Why 83?
Pillar score: (1 + 2 + 2) = 5 of 6 points → 83
Debt-to-Equity0.8×OkayCurrent Ratio1.8×StrongInterest Coverage6.3×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +13.6%Equity ↑ +9.3%D/E 0.8×
Total DebtEquityD/E
6.0b7.3b6.5b6.8b7.9b8.1b8.6b8.6b202320242025TTM0.8×0.9×0.8×0.8×

Borrowings have stayed roughly level: manageable, as long as profits stay healthy.

Short-term assets vs bills, with Current Ratio

Current Assets → +1.3%Current Liabilities ↓ -34.1%Current Ratio 1.8×
Current AssetsCurrent LiabilitiesCurrent Ratio
3.8b4.8b4.0b3.8b3.2b3.3b2.8b2.1b202320242025TTM1.2×1.4×1.4×1.8×
Why 63?
Pillar score: (0 + 2 + 2 + 1) = 5 of 8 points → 63
Dividend Quality1%Weak
Payout ratio: 24%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsPartly healthyOkay
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +36.7%Free CF ↑ +47.2%
Operating CFFree CF
1.3b1.6b1.6b1.8b874m1.1b1.2b1.3b202320242025TTM

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↓ -73.6%Short-Term Debt ↓ -99.9%Total Debt ↑ +13.6%
CashShort-Term DebtTotal Debt
537m1.5b532m142m1000m1.0b500m1m6.0b7.3b6.5b6.8b202320242025TTM

Dividends per Share, with Yield

DPS (cents) ↑ +55.2%Yield % 0.8%
DPS (cents)Yield %
61.961.961.972727272727272185.6267.728828820222023202420250.9%1.4%1.4%0.8%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 33?
Pillar score: (0 + 0 + 2) = 2 of 6 points → 33
P/E Ratio29.1×WeakP/B Ratio3.4×WeakPEG Ratio0.9Strong
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 361.39US$ 305.28US$ 249.18Oct '25Feb '26Jun '26Oct '26

The share price is up about 43.7% over the past year.

Why 75?
Pillar score: (2 + 0 + 2 + 2 + 1 + 2) = 9 of 12 points → 75
Earnings ConsistencySteadyStrongDebt Trend (4yr)RisingWeakShare Count Trend (4yr)-1%/yrStrongInventory vs Sales (4yr)-0.5 pp/yr vs salesStrongAsset Turnover Trend (4yr)+8.3%OkayQuarterly Consistency0 of 4 quarters downStrong
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +20%Inventory ↑ +18.5%Inv. % of Rev. 3.9%
RevenueInventoryInv. % of Rev.
12.2b13.0b14.0b14.6b475m493m535m562m202320242025TTM3.9%3.8%3.8%3.9%
Ranks #9 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#7Cooper Companies66#8Intuitive Surgical66
#9Labcorp (you)65
#10Veeva Systems65#11GE HealthCare64

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B Ratio
2026US$ 14.6bUS$ 1.0bUS$ 1.8bUS$ 1.3bUS$ -528.1mUS$ 141.8mUS$ 6.8bUS$ 0.9mUS$ 8.6bUS$ 3.8bUS$ 2.1bUS$ 18.5bUS$ 9.9bUS$ 562.2m-12%7%0.8×1.8×6.3×24%---
2025US$ 14.0bUS$ 876.5mUS$ 1.6bUS$ 1.2bUS$ -434.5mUS$ 532.3mUS$ 6.5bUS$ 500.1mUS$ 8.6bUS$ 4.0bUS$ 2.8bUS$ 18.4bUS$ 9.8bUS$ 534.7mUS$ 288.0m10%6%0.8×1.4×5.9×27%1%23.4×2.4×
2024US$ 13.0bUS$ 746.0mUS$ 1.6bUS$ 1.1bUS$ -489.9mUS$ 1.5bUS$ 7.3bUS$ 1.0bUS$ 8.1bUS$ 4.8bUS$ 3.3bUS$ 18.4bUS$ 10.3bUS$ 493.2mUS$ 288.0m9%6%0.9×1.4×5.6×33%1%25.2×2.3×
2023US$ 12.2bUS$ 418.0mUS$ 1.3bUS$ 874.1mUS$ -453.6mUS$ 536.8mUS$ 6.0bUS$ 999.8mUS$ 7.9bUS$ 3.8bUS$ 3.2bUS$ 16.7bUS$ 8.8bUS$ 474.6mUS$ 267.7m5%3%0.8×1.2×3.9×61%1%44.2×2.4×